RT Journal Article
T1 QardioArm(R) Blood pressure monitoring in a population with Type 2 diabetes: Validation Study.
A1 Mazoteras Pardo, Victoria
A1 Becerro De Bengoa Vallejo, Ricardo
A1 Losa Iglesias, Marta Elena
A1 Martínez Jiménez, Eva María
A1 Calvo Lobo, César
A1 Romero Morales, Carlos
A1 López López, Daniel
A1 Palomo Lopez, Patricia
AB Background:Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes.Objective:The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension.Methods:The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices.Results:The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes.Conclusions:This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.
PB JMIR Publications
SN 1438-8871
YR 2020
FD 2020-07-24
LK https://hdl.handle.net/20.500.14352/92590
UL https://hdl.handle.net/20.500.14352/92590
LA eng
NO Mazoteras-Pardo V, Becerro-De-Bengoa-Vallejo R, Losa-Iglesias ME, Martínez-Jiménez EM, Calvo-Lobo C, Romero-Morales C, López-López D, Palomo-López P QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study J Med Internet Res 2020;22(7):e19781 doi: 10.2196/19781 PMID: 32706672 PMCID: 7414407
DS Docta Complutense
RD 29 sept 2024